Short interest screen · refreshed after the Nov 11, 2026 close
Short squeeze monitor: Healthcare
Stocks with the largest share of their tradable float sold short. A high share of float sold short means many traders are betting on a decline. If the price rises instead, short sellers may need to buy shares to close their positions, which can add to the move. Days to cover shows how many average trading days that buying would take.
| # | Company | Price | Today | Short % float | Days to cover | Δ short int. | Short vol. 10d | Mkt cap |
|---|---|---|---|---|---|---|---|---|
| 51 | PVLAPalvella TherapeuticsHealthcare | $163.94 | −2.83% | 23.5% | 11.5 | +8% | 58.7% | $2.40B |
| 52 | TNDMTandem Diabetes CareHealthcare | $18.77 | +0.32% | 23.5% | 7.6 | +7% | 52.0% | $1.31B |
| 53 | VSTMVerastemHealthcare | $9.09 | +4.12% | 23.3% | 5.2 | +14% | 46.2% | $1.15B |
| 54 | RNAAtrium TherapeuticsHealthcare | $7.96 | −3.28% | 23.1% | 16.1 | +1% | 33.6% | $136.2M |
| 55 | HROWHarrowHealthcare | $29.37 | −3.26% | 23.0% | 14.1 | −5% | 61.3% | $1.10B |
| 56 | BCAXBicara TherapeuticsHealthcare | $10.53 | +3.44% | 22.8% | 3.8 | −4% | 32.4% | $699.1M |
| 57 | MNPRMonopar TherapeuticsHealthcare | $71.73 | −0.07% | 22.7% | 8.8 | −2% | 53.6% | $481.5M |
| 58 | SPRBSpruce BiosciencesHealthcare | $46.20 | −1.00% | 22.7% | 7.0 | +2% | 59.7% | $132.8M |
| 59 | OMDAOmada HealthHealthcare | $15.24 | +1.20% | 22.6% | 11.4 | +10% | 49.0% | $945.5M |
| 60 | SVRASavaraHealthcare | $4.99 | +1.42% | 22.5% | 12.9 | +12% | 50.0% | $1.10B |
| 61 | SNDXSyndax PharmaceuticalsHealthcare | $9.59 | +1.05% | 22.5% | 6.4 | +5% | 40.3% | $863.4M |
| 62 | LXEOLexeo TherapeuticsHealthcare | $3.07 | +0.33% | 22.2% | 12.7 | −3% | 50.5% | $252.0M |
| 63 | SIONSionna TherapeuticsHealthcare | $3.70 | 0.00% | 22.1% | 4.1 | +15% | 40.0% | $167.4M |
| 64 | CADLCandel TherapeuticsHealthcare | $9.22 | −1.39% | 22.1% | 13.3 | +2% | 59.1% | $705.5M |
| 65 | SANASana BiotechnologyHealthcare | $2.29 | −5.76% | 22.0% | 15.8 | −1% | 55.0% | $686.2M |
| 66 | CRSPCRISPR Therapeutics AGHealthcare | $45.75 | +1.33% | 21.9% | 13.1 | +5% | 48.9% | $4.44B |
| 67 | SCTXScribe TherapeuticsHealthcare | $16.86 | −2.88% | 21.8% | 4.0 | +49% | 74.3% | $319.2M |
| 68 | RZLTRezolute, Inc. Common Stock (NV)Healthcare | $4.07 | +1.24% | 21.8% | 14.9 | −3% | 33.3% | $393.7M |
| 69 | ARTVArtiva BiotherapeuticsHealthcare | $4.07 | +0.25% | 21.7% | 1.8 | +8% | 46.1% | $201.2M |
| 70 | VKTXViking TherapeuticsHealthcare | $28.44 | −0.77% | 21.6% | 5.4 | −5% | 38.1% | $3.63B |
| 71 | SRRKScholar Rock HoldingHealthcare | $46.60 | −2.92% | 21.5% | 13.6 | +6% | 54.8% | $5.69B |
| 72 | IMVTImmunovantHealthcare | $37.04 | +3.72% | 21.4% | 15.3 | +2% | 51.0% | $7.67B |
| 73 | QDELQuidelOrthoHealthcare | $11.91 | +3.39% | 21.4% | 7.6 | +11% | 41.7% | $817.2M |
| 74 | EYENational Vision HoldingsHealthcare | $18.09 | −4.84% | 21.3% | 9.0 | +4% | 49.2% | $1.43B |
| 75 | DNAGinkgo Bioworks HoldingsHealthcare | $10.25 | −14.65% | 21.0% | 3.9 | +14% | 61.9% | $664.5M |
| 76 | IRONDisc MedicineHealthcare | $87.08 | +2.88% | 21.0% | 3.2 | −8% | 40.6% | $3.97B |
| 77 | PACBPacific Biosciences of CaliforniaHealthcare | $2.09 | −6.70% | 20.9% | 4.1 | +14% | 58.2% | $649.6M |
| 78 | ACHCAcadia HealthcareHealthcare | $38.80 | +0.41% | 20.8% | 11.2 | −9% | 38.6% | $3.61B |
| 79 | DSGNDesign TherapeuticsHealthcare | $10.77 | +1.13% | 20.7% | 16.2 | −5% | 67.3% | $689.7M |
| 80 | DMACDiaMedica TherapeuticsHealthcare | $9.66 | −0.10% | 20.6% | 24.8 | −4% | 54.2% | $520.9M |
| 81 | OPTXSyntec Optics HoldingsHealthcare | $6.60 | +22.00% | 20.5% | 6.7 | −3% | 53.4% | $265.8M |
| 82 | ANROAlto NeuroscienceHealthcare | $31.15 | +8.88% | 20.5% | 10.5 | +9% | 63.7% | $1.22B |
| 83 | CYPHCypherpunk TechnologiesHealthcare | $2.00 | −6.10% | 20.4% | 1.2 | +5% | 43.1% | $215.5M |
| 84 | FDMT4D Molecular TherapeuticsHealthcare | $12.99 | +4.25% | 20.4% | 10.4 | −5% | 49.7% | $717.6M |
| 85 | TECXTectonic TherapeuticHealthcare | $21.96 | −0.05% | 20.4% | 13.7 | +7% | 60.0% | $429.3M |
| 86 | NKTRNektar TherapeuticsHealthcare | $38.44 | +1.75% | 20.3% | 10.3 | −3% | 52.0% | $1.31B |
| 87 | CRMDCorMedixHealthcare | $5.30 | −1.30% | 20.2% | 8.4 | −3% | 64.4% | $421.2M |
| 88 | EBSEmergent BiosolutionsHealthcare | $6.04 | −0.17% | 20.0% | 10.1 | +4% | 51.0% | $310.5M |
Data guard: 1 stock withheld — KPLT (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.